Jeffrey Jones, MD, MPH, on Chronic Lymphocytic Leukemia: Optimizing Treatment With New Agents
2016 NCCN Annual Conference (1)Jeffrey Jones, MD, MPH, of the Ohio State University Comprehensive Cancer Center, discusses the use of small molecule inhibitors in developing an individualized treatment plan for patients with CLL.
Related Videos
Toby C. Campbell, MD, on Palliative Care: Patient and Provider Perspectives
Toby C. Campbell, MD, of the University of Wisconsin Carbone Cancer Center, discusses palliative care, hospice care, and best supportive care practices, as well as the challenges of s...
Kevin C. Oeffinger, MD, on Controversies in Breast Cancer Screening Strategies
Kevin C. Oeffinger, MD, of Memorial Sloan Kettering Cancer Center, discusses American Cancer Society recommendations, including the advice that women with an average risk of breast ca...
Sarah L. Blair, MD, on Early-Stage Breast Cancer in Older Women: Surgical Management
Sarah L. Blair, MD, of UC San Diego Moores Cancer Center, discusses surgical resection of breast cancer, which has the best chance of cure and is better than hormonal treatment alone,...
Anne Covey, MD, on Hepatocellular Carcinoma: Guideline Updates for Locoregional Treatment
Anne Covey, MD, of Memorial Sloan Kettering Cancer Center, discusses the role of ablation and arterial-directed therapy in the treatment of hepatocellular carcinoma.
Judith Paice, PhD, RN, on Managing Cancer Pain: Strategies for Prescribing Opioids
Judith Paice, PhD, RN, of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, discusses strategies for safe opioid prescribing: making a comprehensive assessme...
